MOLECULARHEALTH - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
85583345
Registration Number
4710227
Word Mark
MOLECULARHEALTH
Status
710 - Cancelled - Section 8
Status Date
2021-11-19
Filing Date
2012-03-29
Registration Number
4710227
Registration Date
2015-03-31
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
241501, 260101 - Arrows forming a circle or an arc of a circle. Circles as carriers or as single line borders.
Published for Opposition Date
2014-07-01
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
BERNS, LEE ANNE
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"MOLECULAR HEALTH"
Description of Mark
The mark consists of circle within a circle and an arrow within the inner circle and the word "MOLECULARHEALTH" to the right of the image.
Goods and Services
Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer
Goods and Services
Data collection for medical and scientific research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for medical and scientific research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others
Goods and Services
Providing an online database featuring medical, pharmaceutical and genomic information for medical diagnostic or treatment purposes; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; medical consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others
Pseudo Mark
MOLECULAR HEALTH
Pseudo Mark
MOLECULAR HEALTH
Classification Information
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-11-19
Primary Code
035
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-11-19
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-11-19
Primary Code
044
Correspondences
Name
NICOLE E. GAGE
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2012-03-06 | 52645/2012 | Switzerland | True |
2012-03-06 | 52645/2012 | Switzerland | False |
2012-03-06 | Providingan | Switzerland | False |
Trademark Events
Event Date | Event Description |
2012-04-02 | NEW APPLICATION ENTERED IN TRAM |
2012-04-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2012-04-05 | NOTICE OF DESIGN SEARCH CODE MAILED |
2012-07-10 | ASSIGNED TO EXAMINER |
2012-07-22 | NON-FINAL ACTION WRITTEN |
2012-07-22 | NON-FINAL ACTION E-MAILED |
2012-07-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2013-01-22 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2013-01-22 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2013-01-24 | ASSIGNED TO LIE |
2013-01-31 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2013-01-31 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2013-03-07 | EXAMINERS AMENDMENT -WRITTEN |
2013-03-07 | EXAMINERS AMENDMENT E-MAILED |
2013-03-07 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2013-03-07 | EXAMINER'S AMENDMENT ENTERED |
2013-03-14 | SUSPENSION LETTER WRITTEN |
2013-03-14 | LETTER OF SUSPENSION E-MAILED |
2013-03-14 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
2013-09-19 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
2013-09-25 | SUSPENSION INQUIRY WRITTEN |
2013-09-25 | INQUIRY TO SUSPENSION E-MAILED |
2013-09-25 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
2014-03-14 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
2014-03-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2014-03-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2014-04-24 | PRIORITY ACTION WRITTEN |
2014-04-24 | PRIORITY ACTION E-MAILED |
2014-04-24 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
2014-05-15 | EXAMINERS AMENDMENT -WRITTEN |
2014-05-15 | EXAMINERS AMENDMENT E-MAILED |
2014-05-15 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2014-05-15 | EXAMINER'S AMENDMENT ENTERED |
2014-05-22 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2014-05-23 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2014-06-11 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2014-07-01 | PUBLISHED FOR OPPOSITION |
2014-07-01 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2014-07-02 | NOTICE OF PUBLICATION |
2014-08-20 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2014-08-26 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2014-08-28 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2015-02-24 | TEAS DELETE 1(B) BASIS RECEIVED |
2015-02-26 | NOTICE OF ALLOWANCE CANCELLED |
2015-02-26 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
2015-03-31 | REGISTERED-PRINCIPAL REGISTER |
2020-03-31 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
2021-11-19 | CANCELLED SEC. 8 (6-YR) |